MELODIE MILLER: Open Payments
NPI 1699891028 · MIDDLEBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 69 payments from 12 companies in 2025. Trend: 2023 $1,076 · 2024 $1,031 · 2025 $1,493
Food & beverage: $1,481Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $378 |
| Otsuka America Pharmaceutical, Inc. | 11 | $205 |
| Alkermes, Inc. | 9 | $204 |
| Teva Pharmaceuticals USA, Inc. | 10 | $190 |
| E.R. Squibb & Sons, L.L.C. | 9 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $138 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Janssen Biotech, Inc. | 1 | $29 |
| Braeburn Inc. | 1 | $25 |
Products named: VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, COBENFY, CAPLYTA, AUSTEDO XR, INVEGA SUSTENNA, UZEDY.
Industry payments across FL — which companies pay providers there.
